Latest Research in Neuroinflammation and Neurodegeneration Mechanisms

Top Research Topics in Neuroinflammation and Neurodegeneration Mechanisms

• Glioma Diagnosis and Treatment — 7 papers
• Neuroinflammation and Neurodegeneration Mechanisms — 3 papers
• Acute Myeloid Leukemia Research — 3 papers
• S100 Proteins and Annexins — 1 papers
• Single-cell and spatial transcriptomics — 1 papers
• Hippo pathway signaling and YAP/TAZ — 1 papers
• Peptidase Inhibition and Analysis — 1 papers
• Metabolism, Diabetes, and Cancer — 1 papers
• Complement system in diseases — 1 papers
• Developmental Biology and Gene Regulation — 1 papers

Highest-Cited Papers

1. Challenges in Developing a Microglial NF-Kappa B Conditional Mouse Model for Glioblastoma Studies
2. Targeting TGFBR1 with the Investigational Inhibitor TP-6379 Improves Hematopoiesis in Low-Risk MDS Ex Vivo
3. Integrated multi-omics profiling identifies TTYH1 as an astrocyte-associated tumor suppressor in glioma
4. Integrated multi-omics reveals ITGB2 drives the mesenchymal transition in glioblastoma via FAK signaling
5. The Spatiotemporal Evolution of Radiation Resistance in Glioblastoma
6. FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma
7. Serial VAF Kinetics Reveal Dynamic Clonal Evolution Associated With Progression in Clonal Cytopenia of Undetermined Significance
8. F13A1 enhances temozolomide resistance in glioblastoma via activation of the NF-κB signalling pathway
9. Cellular subpopulation remodeling and biphasic molecular dynamics in glioma recurrence: a multi-omics analysis and diagnostic markers screening using liquid biopsy samples
10. Neuroinflammation in Central Nervous System Tumors
11. Identification of FN1 and TIMP1 as macrophage-associated programmed cell death-related prognostic markers in glioblastoma via integrated bulk and single-cell RNA sequencing
12. Why Erythroid Maturation May Not Translate into Clinical Response: A Falsifiable Multilayer Hypothesis for Luspatercept in Myelodysplastic Neoplasms
13. Gliamimic: a longitudinal, multimodal in vitro platform for evaluating glioblastoma treatment response and post-treatment tumor progression in patient-derived organoids or spheroids
14. Beyond the Erythroid Maturation Brake: A Multilayered and Falsifiable Hypothesis for Inadequate Luspatercept Response in Myelodysplastic Neoplasms
15. AMPK Pathway Activation Markers in GBM: Expression Patterns and Clinical Associations in a Real-World Study
16. Complement receptor C3aR marks heterogeneous tumor‐associated macrophage states associated with improved survival in IDH ‐wildtype glioblastoma
17. Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis
18. The HDAC inhibitor panobinostat alleviates radiation-induced splenic B cell injury with concomitant transcriptomic changes in IL-17 signaling
19. 16 Computational dissection of invasive glioblastoma reveals druggable and regulatory targets
20. A TGF-β–SMAD–RUNX1 axis underlies rapid monocyte commitment to a TREM2⁺ immunosuppressive state in human glioblastoma